United States · FDA National Drug Code directory

Arnicare Leg Cramps

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0220-9079_570fbc3a-1c54-e0f6-e063-6394a90a6d25
Product NDC
0220-9079
Form
TABLET
Composition / generic term
ARNICA MONTANA WHOLE, COPPER, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, STRYCHNOS NUX-VOMICA SEED, PASSIFLORA INCARNATA TOP, CLAVICEPS PURPUREA SCLEROTIUM
Labeler
Laboratoires Boiron
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start / end (source format)
20230911
Source listing expiry
20271231

Source-listed ingredients

  • PASSIFLORA INCARNATA TOP — 3 [hp_X]/1
  • COPPER — 4 [hp_C]/1
  • ARNICA MONTANA — 6 [hp_C]/1
  • MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE — 6 [hp_C]/1
  • STRYCHNOS NUX-VOMICA SEED — 6 [hp_C]/1
  • CLAVICEPS PURPUREA SCLEROTIUM — 9 [hp_C]/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 BLISTER PACK in 1 CARTON (0220-9079-04) / 60 TABLET in 1 BLISTER PACK · 0220-9079-04
  • 1 BLISTER PACK in 1 CARTON (0220-9079-29) / 120 TABLET in 1 BLISTER PACK · 0220-9079-29
  • 5 BLISTER PACK in 1 CARTON (0220-9079-92) / 20 TABLET in 1 BLISTER PACK · 0220-9079-92

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →